FOAM: A phase III randomised study of FOlic Acid supplementation in the management of Menopausal symptoms in cancer survivors and healthy postmenopausal women.

The following trial documents are all password protected. 

Change of Staff

If there is a change of staff working on the trial please print off and complete the relevant registration form below. Please also ensure that the Signature and Delegation Log is updated. Return both documents to the FOAM Trial Office.

Trial Documents

Links to the current protocol, Patient Information Sheet(s), Informed Consent Form(s) are provided below. If there has been a recent amendment to the trial please ensure you have R&D approval before using these documents.

Other documents (e.g. Amendments, Case Report Form, Serious Adverse Event Form, Guidelines, GP Letter etc) can be found by clicking on the other menu items below. If you cannot find what you are looking for please contact the FOAM Trial Office. 

Version Control Lists

The version numbers and dates of all documents used for the trial are captured on a Document Version Control List. Links to the Document Version Control Lists used in this trial are below in reverse date order.


Below is a link to a document which lists all of the substantial protocol amendments which have been made for this trial. The folders below contain the relevant amended documentation and approval letters. Please ensure that you have R&D approval (if applicable) before using the latest versions of these documents.

Case Report Form


Other Trial Documents

News and Events


Contact Details

Chief Investigator

Mr Ayman Ewies, Sandwell & West Birmingham NHS Trust, Birmingham City Hospital, Dudley Road, Birmingham, West Midlands B18 7QH

Tel: 0121 507 4042


FOAM Trial Office

Trial Coordinator:  
Senior Trial Coordinator: Rachel Blundred
Trial Management Team Leader:  Claire Gaunt
Trial Statistician:    Ikhlaaq Ahmed

Cancer Research UK Clinical Trials Unit (CRCTU)
Institute of Cancer and Genomic Sciences
University of Birmingham
B15 2TT


Tel: 0121 414 3792 
Fax: 0121 414 8392

Trial Entry

Tel: 0121 414 3792 or 0800 371 969   (9.00 am till 5.00 pm Monday to Friday)

Serious Adverse Event Reporting

Fax: 0121 414 8392 or 0121 414 7989


Sandwell and West Birmingham Hospitals NHS Trust and University of Birmingham